Chemopreventive potential of curcumin in prostate cancer
about
Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.Curcumin and cancer: barriers to obtaining a health claim.Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53.Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cellsOutsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancerCurcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cellsCoffee provides a natural multitarget pharmacopeia against the hallmarks of cancer.Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer.Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer AgentsCytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell linePyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation.Nanoformulation of natural products for prevention and therapy of prostate cancer.Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.Dietary flavonoids as cancer prevention agents.TRAIL-mediated signaling in prostate, bladder and renal cancer.Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.Anti-proliferative effect and induction of apoptosis in androgen-independent human prostate cancer cells by 1,5-bis(2-hydroxyphenyl)-1,4-pentadiene-3-one.Plumbagin modulates leukemia cell redox status.Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model.Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.A monocarbonyl analogue of curcumin, 1,5-bis(3-hydroxyphenyl)-1,4-pentadiene-3-one (Ca 37), exhibits potent growth suppressive activity and enhances the inhibitory effect of curcumin on human prostate cancer cells.Anticancer Natural Compounds as Epigenetic Modulators of Gene ExpressionProperties of lewis lung carcinoma cells surviving curcumin toxicityCurcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.Design of curcumin loaded cellulose nanoparticles for prostate cancer.Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP.Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancerEffects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin.Modulation of AKR1C2 by Curcumin Decreases Testosterone Production in Prostate Cancer.HSP27 modulates survival signaling in endosulfan-exposed human peripheral blood mononuclear cells treated with curcumin.Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapyDiscovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition
P2860
Q34284547-06D3394B-62C5-4E9C-8E2A-A42C51578C8FQ34454413-0318059A-AA4A-410B-97C7-34712B3F07EBQ34478532-08A3942E-6406-4C2D-B39A-260F86E66EF2Q34602465-F246A263-3D6B-42D6-A3B5-7790AB49A72CQ34851241-8FDAFA5B-7A7F-4BE6-911A-4BA14C2F5BD2Q34991240-502627CE-E9DF-4A6A-9B35-C4DD5CBAA202Q35786826-C22DEBB1-71D7-4510-856F-711C8C0F8A8BQ35834796-466818F5-9FD2-491F-96E0-F78330646A4DQ36289486-C4579DC5-5829-4F96-BA9A-00F266C608E7Q36412424-3514F4DC-60E7-4F12-8E63-04EB0252FF9DQ36581767-46516A1B-DFF4-4B9E-9413-9CF64A086B0DQ36782889-356741AF-2D0F-4906-8589-284BC687146AQ36804628-54778BB1-D176-43F9-A85A-7AF2908DF60BQ36954564-B99A23DE-DD6C-4FD2-806A-93CD1DCC89FBQ37473193-A988D286-6C47-4C16-B8C2-981FE76A7D20Q37576761-F854563D-9A8E-4B64-A998-BC157729992FQ37855700-EE622977-B94E-4573-AE89-53983B30259DQ37889112-EF4F776A-C21D-4E1C-A97D-5C9C79596DF6Q38700661-FF949EB9-BEEE-45F6-B20F-555D45097260Q38750969-91F10845-0BBE-49DD-ADB0-0D7F6208222DQ38847739-6CAFB92F-6D06-4B34-A569-5B12907B63E7Q38908668-B1D7802D-AD6B-45D5-94BF-FA541E9C5578Q38976316-AD534BCF-B3F0-46D4-9809-C050D12A4AE2Q38998361-DC90BC26-CBD5-4E1D-8ACA-EAD0DA5D3257Q39023495-D4AF646E-1E99-404A-B14F-36A0AE38B828Q39050767-FC358633-7C05-4694-9D87-70A987E74D83Q39214234-96C13F77-3E09-4FEE-9F01-2FF4C7DEE83AQ39414511-93927EE3-77D8-48F0-8C35-AE4168D1E226Q39470443-C8223641-CDE4-4806-97B0-63D5CDF1850AQ39479428-1D7560BA-B94D-4EE9-920C-5DBA82CE4795Q39623453-D36AB848-0C8C-4205-87E3-E770B7F9C02AQ41264734-CE725C95-4E4E-4929-9B6E-AEF11A1C6D57Q42151185-48B02826-1363-4E6B-950E-C3B98A72E1E4Q42558465-416951BD-A837-402C-8483-54ADB73B3635Q49711327-1245702E-21BD-4145-AEDA-6FE517ADCD2CQ52812928-12D339B9-8965-467B-957B-CD02D90DCFEDQ52907990-3F1EEC3B-3AF5-4821-9945-2A05A6DBEB1AQ57074587-C133FC4A-2EE9-4AB0-8360-C4BE2880BDC3Q57163862-00AD4240-4BB4-4459-B688-687C2F90FE43
P2860
Chemopreventive potential of curcumin in prostate cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemopreventive potential of curcumin in prostate cancer
@ast
Chemopreventive potential of curcumin in prostate cancer
@en
type
label
Chemopreventive potential of curcumin in prostate cancer
@ast
Chemopreventive potential of curcumin in prostate cancer
@en
prefLabel
Chemopreventive potential of curcumin in prostate cancer
@ast
Chemopreventive potential of curcumin in prostate cancer
@en
P2093
P2860
P1433
P1476
Chemopreventive potential of curcumin in prostate cancer
@en
P2093
François Gaascht
Marie-Hélène Teiten
Mario Dicato
Serge Eifes
P2860
P2888
P356
10.1007/S12263-009-0152-3
P577
2009-10-06T00:00:00Z
P5875
P6179
1041305674